Advertisement

Interaction of Antisera to the Secretory Component with FcαR

  • S. S. Crago
  • C. J. Word
  • T. B. Tomasi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 216 A)

Abstract

The predominant immunoglobulin (Ig) in human external secretions is secretory IgA (SIgA) (1) which appears to be produced largely by IgA-containing plasma cells underlying the mucosal epithelium (1,2). IgA is unique in that two distinct receptors for the Fc portion of the molecule exist, the secretory component (SC) and the Fc receptor for IgA (FcaR) (3). SC is a glycoprotein associated with the epithelial cells lining mucosal surfaces (4), and functions both as a receptor for polymeric IgA and IgM and as a transport molecule in the translocation of Igs across secretory epithelium into exocrine fluids (4,5). The FcaR has been reported to be present on both B and T lymphocytes, monocytes and polymorphonuclear leukocytes (PMN) in a number of species (3). While the role of I FcaR on these cells is not clear, there is evidence that T cells which express membrane-bound Fc receptors may regulate Ig production in an isotype- specific manner both in vivo and in vitro. In some cases, this regulation is mediated via the release of soluble, isotype-specific Ig binding factors from FcR+ T cells (3).

Keywords

Cell Surface Molecule Murine Cell Human Peripheral Blood Lymphocyte Secretory Component Rosette Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tomasi, T.B., Tan, E.M., Solomon, A. and Prendergast, R.A., J. Exp. Med. 121, 101, 1965.PubMedCrossRefGoogle Scholar
  2. 2.
    Brandtzaeg, P., Clin. Exp. Immunol. 44, 221, 1981.PubMedGoogle Scholar
  3. 3.
    Word, C.J., Crago, S.S. and Tomasi, T.B., Ann. Rev. Microbiol. 40, 503, 1986.CrossRefGoogle Scholar
  4. 4.
    Brandtzaeg, P., Ann. N.Y. Acad. Sci. 409, 353, 1983.PubMedCrossRefGoogle Scholar
  5. 5.
    Crago, S.S., Kulhavy, R., Prince, S.J. and Mestecky, J., J. Exp. Med. 147, 1832, 1978.PubMedCrossRefGoogle Scholar
  6. 6.
    Boyum, A., Scand. J. Clin. Invest. 21, 7, 1968.Google Scholar
  7. 7.
    Hoover, R.G., Dieckgraefe, B.K. and Lynch, R.G., J. Immunol. 127, 1560, 1981.PubMedGoogle Scholar
  8. 8.
    Mestecky, J., Hammack, W.J., Kulhavy, R., Wright, G.P. and Toraana, M., J. Lab. Clin. Med. 89, 919, 1977.PubMedGoogle Scholar
  9. 9.
    Underdown, B.J. and Socken, D.J., Adv. Exp. Med. Biol. 107, 503, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Gebel, H.M., Hoover, R.G., Lynch, R.G., J. Immunol. 123, 1110, 1979.PubMedGoogle Scholar
  11. 11.
    Ravetch, J.V., Luster, A.D., Weinshank, R., Kochan, J., Pavlovec, A., Portnoy, D.A., Hulmes, J., Pan, Y-C.E. and Unkeless, J., Science 234, 718, 1986.PubMedCrossRefGoogle Scholar
  12. 12.
    Jardieu, P., Moore, K., Martens, C. and Ishizaka, K., J. Immunol. 135, 2727, 1985.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • S. S. Crago
    • 1
  • C. J. Word
    • 1
  • T. B. Tomasi
    • 2
  1. 1.Department of Cell BiologyUniversity of New MexicoAlbuquerqueUSA
  2. 2.Roswell Park Memorial InstituteBuffaloUSA

Personalised recommendations